Experience in Studying Herd and Individual Immunity to the SARS-CoV-2 Virus in Medical Workers

Author:

Reshetnikova I. D.1,Agafonova E. V.2,Tyurin Yu. A.2,Kulikov S. N.1,Gilyazutdinova G. F.3,Lopushov D. V.4,Shaykhrazieva N. D.5,Isaeva G. Sh.2,Ziatdinov V. B.3

Affiliation:

1. Kazan Research Institute of Epidemiology and Microbiology; Kazan (Privolzhsky) Federal University

2. Kazan Research Institute of Epidemiology and Microbiology; Kazan State Medical University of the Ministry of Health of Russia

3. Kazan Research Institute of Epidemiology and Microbiology

4. Kazan State Medical University of the Ministry of Health of Russia; Kazan State Medical Academy of the Ministry of Health of Russia

5. Kazan State Medical Academy of the Ministry of Health of Russia

Abstract

The aim was to study SARS-CoV-2 immunity among medical workers in Kazan.Materials and methods. Studied were serum samples from 348 medical workers from 10 medical organizations in Kazan, divided into groups according to the level of the alleged risk of infection of employees. To determine IgG, a two-stage direct version of the solid-phase ELISA and the test-system “SARS-CoV-2-IgG-ELISA-BEST” (Russia) were used.Results and discussion. At the time of the study and over the previous three months, the examined medical workers had no symptoms of acute respiratory viral infection or respiratory tract infections; there were negative results of examining nasopharyngeal/ oropharyngeal swabs for the presence of SARS-CoV-2 RNA. Seroprevalence for IgG to SARS-CoV-2 virus for different medical organizations in Kazan ranged within the scope of 3.3–30.8 % and averaged 16.4 %. The wide variation in seroprevalence values in medical workers of different medical organizations may indicate different levels of intensity of professional contacts and the effectiveness of anti-epidemic measures in these medical organizations. Among medical workers with seropositive results, the prevalence of persons with a very high coefficient of positivity (49.1 %) is observed, which characterizes high level of antiviral antibodies. The presence of a high proportion of seropositive individuals among medical workers, who have had an asymptomatic form of COVID-19 confirms the high intensity of the latent epidemic process, which must be taken into account when organizing preventive measures, including vaccination. 

Publisher

Russian Research Anti-Plague Institute Microbe

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Epidemiology

Reference22 articles.

1. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China, 2020. The novel co¬ ronavirus pneumonia emergency response epidemiology team. China CDC Weekly. 2020; 2(8):113–122. DOI: 10.46234/ccdcw2020.032.

2. Kutyrev V.V., Popova A.Yu., Smolenskiy V.Yu., Ezhlova E.B., Demina Yu.V., Safronov V.A., Karnaukhov I.G., Ivanova A.V., Shcherbakova S.A. [Epidemiological Peculiarities of New Coro¬ navirus Infection (COVID-2019). Communication 2: Peculiarities of epidemic process development in conjunction with performed antiepidemic measures around the world and in the Russian Federation]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2020; 2:6–12. DOI: 10.21055/0370-10692020-2-6-12.

3. Lombardi A., Consonni D., Carugno M., Bozzi G., Mangioni D., Muscatello A., Castelli V., Palomba E., Cantù A.P. Ceriotti F., Tiso B., Pesatori A.C., Riboldi L., Bandera A., Lunghi G., Gori A. Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy. Clin. Microbiol. Infect. 2020; 26(10):1413.e9-1413.e13. DOI: 10.1016/j.cmi.2020.06.013.

4. Takita M., Matsumura T., Yamamoto K., Yamashita E., Hosoda K., Hamaki T., Kusumi E. Preliminary results of seroprevalence of SARS-CoV-2 at community clinics in Tokyo. medRxiv. DOI: 10.1101/2020.04.29.20085449.

5. Liu T., Wu S., Tao H., Zeng G., Zhou F., Guo F., Wang X. Prevalence of IgG antibodies toSARS-CoV-2 in Wuhan – implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2. medRxiv. DOI: 10.1101/2020.06.13.20130252.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3